University of Wisconsin–Madison

Federal Funding Opportunities, August 9-September 10, 2021

Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) (PAR-21-313) National Institute of Diabetes and Digestive and Kidney Diseases National Human Genome Research Institute Application Receipt Date(s): September 07, 2024 Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) (PAR-21-305) National Institute of Diabetes and Digestive and Kidney Diseases National Cancer Institute Eunice Kennedy Shriver National Institute of Child Health and Human Development Office of Disease Prevention Application Receipt Date(s): September 22, 2021 (first deadline) Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD/ADRD (R01 Clinical Trial Not Allowed) (PAR-22-026) National Institute of Neurological Disorders and Stroke National Institute on Aging Application Receipt Date(s): November 8, 2021 Autism Centers of Excellence: Networks (R01 Clinical Trial Optional) (RFA-HD-22-007) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Deafness and Other Communication Disorders National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): November 9, 2021 Autism Centers of Excellence: Centers (P50 Clinical Trial Optional) (RFA-HD-22-008) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Deafness and Other Communication Disorders National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): November 9, 2021 Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed) (PAR-22-024) National Institute of Neurological Disorders and Stroke National Institute on Aging Application Receipt Date(s): November 10, 2021 Feasibility Studies that Explore Healthy and Diseased Temporomandibular Joints (TMJ) using Single Cell Multi-Omic Analyses (UH2/UH3 Clinical Trial Not Allowed) (RFA-DE-22-005) National Institute of Dental and Craniofacial Research Office of Research on Women’s Health Application Receipt Date(s): November 10, 2021 Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed) (RFA-ES-21-008) National Institute of Environmental Health Sciences Application Receipt Date(s): November 10, 2021 Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed) (RFA-ES-21-009) National Institute of Environmental Health Sciences Application Receipt Date(s): November 10, 2021 Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required) (RFA-NS-22-009) National Institute of Neurological Disorders and Stroke National Institute on Aging Application Receipt Date(s): November 10, 2021 Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional) (RFA-DA-22-022) National Institute on Drug Abuse Application Receipt Date(s): November 11, 2021 Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-NS-22-017) National Institute of Neurological Disorders and Stroke National Institute on Aging Application Receipt Date(s): November 12, 2021 Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 – Clinical Trial Not Allowed) (PAR-21-277) National Institute of General Medical Sciences National Center for Complementary and Integrative Health National Heart, Lung, and Blood Institute National Institute of Allergy and Infectious Diseases National Institute of Dental and Craniofacial Research National Institute of Mental Health National Library of Medicine Office of Research on Women’s Health Application Receipt Date(s): November 18, 2021 November 15, 2022 November 15, 2023 Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional) (RFA-HD-22-009) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): November 29, 2021 Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 – Clinical Trial Required) (RFA-MD-22-001) National Institute on Minority Health and Health Disparities National Institute of Mental Health Application Receipt Date(s): January 14, 2022 American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional) (RFA-AI-21-058) National Institute of Allergy and Infectious Diseases National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Mental Health Office of Behavioral and Social Sciences Research Office of Research on Women’s Health Application Receipt Date(s): See announcement Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) (PAR-21-307) National Institute on Aging Application Receipt Date(s): Multiple dates, see announcement. Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required) (PAR-21-308) National Institute on Aging Application Receipt Date(s): Multiple dates, see announcement. Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed) (PAR-21-297) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Allergy and Infectious Diseases National Institute of Mental Health Application Receipt Date(s): See announcement Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed) (PAR-21-298) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Mental Health Application Receipt Date(s): See announcement